Plain English
GovGreed Synthesis ·
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Market Impact Map
Action Timeline
2025-01-03
Referred to the House Committee on Energy and Commerce.
2025-01-03
Introduced in House
2025-01-03
Introduced in House
Full Bill Text
119 HR 124 IH: Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 U.S. House of Representatives 2023-01-09 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 124 IN THE HOUSE OF REPRESENTATIVES January 3, 2025 Mr. Green of Texas introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease. 1. Short title This Act may be cited as the Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 . 2. Providing incentives for education on risk of renal medullary carcinoma to individuals with Sickle Cell Disease under Medicaid (a) In general Section 1903(a)(3)(E)(ii) of the Social Security Act ( 42 U.S.C. 1396b(a)(3)(E)(ii) ) is amended by inserting , renal medullary carcinoma, after stroke each place it appears. (b) Effective date The amendments made by subsection (a) shall apply with respect to items and services furnished on or after the date of the enactment of this Act.
Loading intelligence layer…